Results 1 to 10 of about 135 (83)
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Non-structural protein 3 (nsp3) from all coronaviruses (CoVs) contains a conserved macrodomain, known as Mac1, that has been proposed as a potential therapeutic target for CoVs due to its critical role in viral pathogenesis. Mac1 is an ADP-ribose binding
Dana Ferraris +2 more
exaly +3 more sources
Intracellular pathogens residing within macrophage phagosomes are challenged with recognizing the phagosomal environment and appropriately responding to changing host defense strategies imposed in this organelle.
Chad Rappleye, Stephanie C Ray
exaly +3 more sources
Since the emergence of SARS-CoV-2, many genetic variations within its genome have been identified, but only a few mutations have been found in nonstructural proteins (NSPs).
Simone Brogi +2 more
exaly +3 more sources
Recent studies suggest that improper resolution of acute neuroinflammation may lead to long-lasting low-grade chronic neuroinflammation and drive progressive neurodegeneration.
Jau-Shyong Hong +2 more
exaly +3 more sources
Background β-Amyloid peptide (Aβ) is a major protein in the brain associated with Alzheimer's and Parkinson's diseases. The purpose of this study was to investigate the role of macrophage antigen-1 (MAC1) receptor, an integrin scavenger receptor in ...
, Jau-Shyong Hong, Shih-Heng Chen
exaly +3 more sources
All coronaviruses (CoVs) encode a conserved macrodomain, termed Mac1, in non-structural protein 3 (nsp3) that binds and hydrolyzes ADP-ribose covalently attached to proteins.
Fei Gao, Anuradha Roy, Anthony Fehr
exaly +3 more sources
Introduction The mechanisms of cognitive impairments in Parkinson’s disease (PD) remain unknown. Accumulating evidence revealed that brain neuroinflammatory response mediated by microglial cells contributes to cognitive deficits in neuropathological ...
Liyan Hou +8 more
doaj +1 more source
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP-ribosylhydrolase activity and a possible drug target.
Taha Y Taha +16 more
doaj +1 more source
Nitric oxide-mediated antioxidative mechanism in yeast through the activation of the transcription factor Mac1. [PDF]
The budding yeast Saccharomyces cerevisiae possesses various defense mechanisms against environmental stresses that generate reactive oxygen species, leading to growth inhibition or cell death.
Ryo Nasuno +5 more
doaj +1 more source
Regulation of Copper Metabolism by Nitrogen Utilization in Saccharomyces cerevisiae
To understand the relationship between carbon or nitrogen utilization and iron homeostasis, we performed an iron uptake assay with several deletion mutants with partial defects in carbon or nitrogen metabolism. Among them, some deletion mutants defective
Suzie Kang +3 more
doaj +1 more source

